Impact of COVID-19 on Pharmaceuticals Market Size, Share & Industry Analysis
The global pharmaceuticals market size is set to decline marginally in 2020, from the pre-coronavirus outbreak projection of USD 1,316.0 billion to USD 1,310.0 billion, exhibiting a CAGR of 4.0% for the current year. Fortune Business Insights™ has revised its analysis of this market and brought out a special report, titled “Impact Of Covid-19 On The Pharmaceuticals Market”, to study the short- and long-term effects of the pandemic on the growth of this market. According to Johns Hopkins University in the US, the global tally of confirmed COVID-19 cases has risen to 2.7 million, with the death toll standing at around 190,000 as of April 24, 2020. With most countries facing a treatment-deficit for this infection, pharmaceutical companies have diverted all their investment energies towards developing quick and effective drugs to cure affected people.
Request
Sample Copy: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/impact-of-covid-19-on-pharmaceuticals-market-102685
List of
Companies Covered in the Report:
·
GlaxoSmithKline plc. (London, U.K)
·
F. Hoffmann-La Roche Ltd. (Basel, Switzerland)
·
Novartis AG (Basel, Switzerland)
·
Johnson & Johnson Services Inc. (New Jersey, U.S.)
·
Merck & Co., Inc. (New Jersey, U.S.)
·
Pfizer (New York, U.S.)
·
AstraZeneca (Cambridge, U.K.)
·
Sanofi (Paris, France)
·
Novo Nordisk A/S (Copenhagen, Denmark)
Growing
Preference for Telemedicine to Create Several Avenues for Expansion
The COVID-19 outbreak has forced governments to impose nationwide lockdowns
and social distancing norms, choking economic activity and shutting down
businesses. Fear of getting infected has led people to avoid crowded places and
healthcare facilities in particular. As a result, there is a paradigmatic shift
in preference from physical interface to virtual interaction with health and
medical professionals. For example, in March, Boston Medical Center in the US
launched a telemedicine site and within two days it managed to get 1500
patients onboard. Similarly, the University of South California has been
actively promoting the telemedicine route for seeking medical advice. In India,
the Medical Council of India and the NITI Aayog prepared telemedicine
guidelines for doctors to prescribe mild drugs such as paracetamol and provide tele-consultation
services to patients. Thus, the spread of the coronavirus has spiked the
adoption of telemedicine, which is likely to mitigate some of the negative
effects that the pharmaceutical industry is being expected to bear.
Market
Players to Singularly Focus on Clinical Trials for COVID-19 Treatment Drugs
The pharmaceuticals market is primarily composed of pharmaceutical giants
such as Pfizer and GlaxoSmithKline, who are putting in intensive efforts to
develop effective solutions for the COVID-19 infections. While research on
vaccine for the infection is also taking place simultaneously, the immediate
concern is to provide efficient treatment to coronavirus patients around the
world.
North
America to Lead the Market Share as COVID-19 Cases Skyrocket in the US
In 2018, North America accounted for 47.0% of the global market, thereby
dominating the pharmaceuticals market share. In 2020 as well, the region is
expected to lead the market on account of skyrocketing number of infected
people in the US. According to the Centers for Disease Control and Prevention
(CDC), as of April 22, confirmed coronavirus cases in the US were at 828,441
and the death tally stood at 46,379. Pharmaceutical giants based in the US have,
therefore, spurred into action to develop treatments and vaccines for the
infection, whilst continuing their development of medication for other
co-morbid diseases such as diabetes and cancer. Thus, the market in North
America is likely to remain steady, since the US and Canadian governments have
poured massive amounts of funds into biomedical research and development
activities.
About Us:
Fortune
Business Insights™ offers expert corporate analysis and accurate data, helping
organizations of all sizes make timely decisions. We tailor innovative
solutions for our clients, assisting them address challenges distinct to their
businesses. Our goal is to empower our clients with holistic market
intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis
to help companies achieve sustainable growth. Our team of experienced analysts
and consultants use industry-leading research tools and techniques to compile
comprehensive market studies, interspersed with relevant data.
Contact Us:
Fortune
Business Insights Pvt. Ltd.
9th
Floor, Icon Tower, Baner - Mahalunge Road,
Baner,
Pune-411045,
Maharashtra,
India.
Phone:
US :+1
424 253 0390
UK : +44
2071 939123
APAC :
+91 744 740 1245
Email:
mailto:sales@fortunebusinessinsights.com
Comments
Post a Comment